自噬
串扰
程序性细胞死亡
细胞凋亡
细胞生物学
癌细胞
生物
癌症研究
癌症
机制(生物学)
细胞
生物化学
遗传学
哲学
物理
光学
认识论
作者
Shreya Das,Nidhi Shukla,Shashi Shekhar Singh,Sapana Kushwaha,Richa Shrivastava
出处
期刊:Apoptosis
[Springer Nature]
日期:2021-09-12
卷期号:26 (9-10): 512-533
被引量:133
标识
DOI:10.1007/s10495-021-01687-9
摘要
The mechanisms of two programmed cell death pathways, autophagy, and apoptosis, are extensively focused areas of research in the context of cancer. Both the catabolic pathways play a significant role in maintaining cellular as well as organismal homeostasis. Autophagy facilitates this by degradation and elimination of misfolded proteins and damaged organelles, while apoptosis induces canonical cell death in response to various stimuli. Ideally, both autophagy and apoptosis have a role in tumor suppression, as autophagy helps in eliminating the tumor cells, and apoptosis prevents their survival. However, as cancer proceeds, autophagy exhibits a dual role by enhancing cancer cell survival in response to stress conditions like hypoxia, thereby promoting chemoresistance to the tumor cells. Thus, any inadequacy in either of their levels can lead to tumor progression. A complex array of biomarkers is involved in maintaining coordination between the two by acting as either positive or negative regulators of one or both of these pathways of cell death. The resulting crosstalk between the two and its role in influencing the survival or death of malignant cells makes it quintessential, among other challenges facing chemotherapeutic treatment of cancer. In view of this, the present review aims to highlight some of the factors involved in maintaining their diaphony and stresses the importance of inhibition of cytoprotective autophagy and deletion of the intermediate pathways involved to facilitate tumor cell death. This will pave the way for future prospects in designing drug combinations facilitating the synergistic effect of autophagy and apoptosis in achieving cancer cell death.
科研通智能强力驱动
Strongly Powered by AbleSci AI